A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

The serine/threonine protein kinase mechanistic target of rapamycin (mTOR) is evolutionarily conserved and modulates protein synthesis, cell growth, and cellular autophagy in response to distinct ...

Cytotoxic T lymphocytes play a crucial role in adaptive immunity, primarily defending against tumors and viruses. These cells develop within the thymus gland and undergo rapid activation upon ...

Angelini Pharma has licensed a preclinical-stage mTOR inhibitor from South Korean biotech Sovargen with potential for genetic forms of epilepsy and other brain disorders. The $550 million-plus deal ...

Cummins Inc. CMI recently announced that it will acquire Meritor, Inc. MTOR to reinforce its electric and hybrid vehicle parts offerings. The deal comes at a time when the demand for climate-friendly ...

Variation in health-related quality of life (HRQOL) by line of therapy, age, and gender among patients with chronic lymphocytic leukemia. Predictive factors associated with achievement of major ...